MF
ABMD

Magnetar Financial’s Abiomed Inc ABMD Stock Holding History

Magnetar Financial’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,611
Closed -$396K – 1311
2022
Q3 		$396K Buy
+1,611
New +$435K 0.01% 854
2021
Q1 		– Sell
-1,420
Closed -$460K – 1233
2020
Q4 		$460K Sell
1,420
-2,992
-68% -$828K 0.01% 573
2020
Q3 		$1.22M Buy
+4,412
New +$1.27M 0.02% 315

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Magnetar Financial's ABMD Position: Q4 2022 in Review

Magnetar Financial sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,611 shares — an estimated $396K sold.

Magnetar Financial first reported a position in ABMD in Q3 2020 and held it in 3 quarters. The position peaked at $1.22M in Q3 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Magnetar Financial reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Magnetar Financial sold 1,611 Abiomed Inc shares in Q4 2022, an estimated $396K.
  • Magnetar Financial first reported a position in Abiomed Inc in Q3 2020 and held it in 3 quarters.
  • Magnetar Financial's Abiomed Inc position peaked at $1.22M in Q3 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Magnetar Financial's 13F filing for Q4 2022, filed 14 Feb 2023.